Literature DB >> 25515524

A spinal tumor showing mixed features of ependymoma and hemangioblastoma: a case report and literature review.

Hai-Xia Cheng1, Shu-Guang Chu, Qi-Wu Xu, Yin Wang.   

Abstract

We report an intramedullary spinal tumor consisting of an ependymoma and a hemangioblastoma (HB). A 37-year-old woman presented with progressive bilateral lower limb sensory and motor deficits. Magnetic resonance imaging showed a single intramedullary mass in the thoracic cord (T4-T6 level). Clinically, the patient had no von Hippel-Lindau disease and neurofibromatosis type 2. Metastatic carcinomas including renal cell carcinoma were altogether negative. Complete surgical resection was performed. Histologically, the tumor consisted of a mixed ependymoma and HB. Tumor cells of ependymoma displayed a rather uniform appearance with round to oval nuclei having salt-and-pepper-like chromatin, forming perivascular pseudorosette structures with radially arranged, tapering cell processes extending to intratumoral blood vessels. Stromal cells of HB had vacuolated or homogeneously eosinophilic cytoplasm and variable sized hyperchromatic nuclei within a background of capillaries. Immunohistochemically, tumor cells of ependymoma were strongly positive for glial fibrillary acidic protein (GFAP), focally positive for epithelial membrane antigen (EMA) and D2-40 in a dot-like or ring-like pattern. Stromal cells of HB showed immunoreactivity for S100, vimentin, inhibin-α, D2-40, EMA and cytokeratins (CK: AE1/AE3, CK19). A review of the literature, in conjunction with the present case, shows that ependymomas and HBs may have a close relationship with each other.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25515524     DOI: 10.1007/s10014-014-0208-y

Source DB:  PubMed          Journal:  Brain Tumor Pathol        ISSN: 1433-7398            Impact factor:   3.298


  1 in total

1.  Sporadic Hemangioblastoma Arising from the Infundibulum.

Authors:  Michael N Pakdaman; Matthew J Austin; Serguei Bannykh; Barry D Pressman
Journal:  J Radiol Case Rep       Date:  2017-05-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.